Nicholas Grund
Chief Commercial Officer at Akebia Therapeutics · 3 reported transactions in 1 company · latest trade Feb 2, 2026
Their trades
Sold | Feb 2, 2026 | Feb 2, 2026 close $1.38 → Oct 23, 2026 close $0.57. S&P 500 +9.3% over the same days. | ||
Sold | Feb 2, 2026 | Feb 2, 2026 close $1.38 → Oct 23, 2026 close $0.57. S&P 500 +9.3% over the same days. |
$43.4K
Feb 2, 2026 close $1.38 → Oct 23, 2026 close $0.57. S&P 500 +9.3% over the same days.
$74.5K
Feb 2, 2026 close $1.38 → Oct 23, 2026 close $0.57. S&P 500 +9.3% over the same days.